See more : Beingmate Co., Ltd. (002570.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Natura &Co Holding S.A. (NTCO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Natura &Co Holding S.A., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Mota-Engil, SGPS, S.A. (EGL.LS) Income Statement Analysis – Financial Results
- PREMIER ENERGIES LIMITED (PREMIERENE.NS) Income Statement Analysis – Financial Results
- Wisr Limited (WZR.AX) Income Statement Analysis – Financial Results
- Sandu Pharmaceuticals Limited (SANDUPHQ.BO) Income Statement Analysis – Financial Results
- Northern Minerals & Exploration Ltd. (NMEX) Income Statement Analysis – Financial Results
Natura &Co Holding S.A. (NTCO)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://ri.naturaeco.com/en
About Natura &Co Holding S.A.
Natura &Co Holding S.A. develops, manufactures, distributes, and sells cosmetics, fragrances, and personal hygiene products. The company's products portfolio includes body care, face care, makeup, soaps, hair care, deodorants, oils, and other products, as well as deodorants, men's grooming, and sun protection products. It markets its products under the Natura, Aesop, Avon, and The Body Shop brands through signature and department stores, e-commerce, direct selling, business-to-business, franchises, physical stores, and retail markets primarily in Asia, North America, South America, Europe, the Middle East, Africa, and Oceania. Natura &Co Holding S.A. was founded in 1969 and is headquartered in São Paulo, Brazil.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 26.74B | 36.35B | 40.16B | 36.92B | 14.44B | 13.40B | 9.85B | 7.91B | 7.90B | 7.41B | 7.01B | 6.35B |
Cost of Revenue | 9.68B | 13.16B | 14.01B | 13.23B | 4.03B | 3.78B | 2.91B | 2.63B | 2.58B | 2.25B | 2.11B | 1.87B |
Gross Profit | 17.06B | 23.19B | 26.15B | 23.69B | 10.41B | 9.61B | 6.94B | 5.28B | 5.32B | 5.16B | 4.90B | 4.48B |
Gross Profit Ratio | 63.81% | 63.81% | 65.11% | 64.17% | 72.08% | 71.76% | 70.45% | 66.76% | 67.39% | 69.63% | 69.89% | 70.56% |
Research & Development | 161.48M | 273.43M | 223.47M | 270.26M | 89.68M | 102.44M | 80.03M | 76.65M | 208.81M | 218.13M | 183.23M | 158.87M |
General & Administrative | 1.35B | 6.91B | 5.60B | 5.96B | 2.41B | 1.96B | 1.54B | 1.10B | 1.27B | 1.13B | 1.04B | 792.28M |
Selling & Marketing | 7.75B | 15.55B | 17.00B | 15.70B | 6.40B | 5.83B | 3.97B | 3.34B | 3.02B | 2.68B | 2.45B | 2.21B |
SG&A | 14.43B | 22.47B | 22.60B | 21.66B | 8.80B | 7.79B | 5.50B | 4.25B | 4.13B | 3.81B | 3.49B | 3.10B |
Other Expenses | 2.63B | 506.87M | 855.99M | 245.94M | 255.90M | 135.02M | -250.20M | -13.86M | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 17.22B | 23.25B | 23.68B | 22.18B | 9.06B | 8.02B | 5.25B | 4.27B | 4.13B | 4.02B | 3.61B | 3.14B |
Cost & Expenses | 26.89B | 36.40B | 37.69B | 35.40B | 13.09B | 11.81B | 8.16B | 6.90B | 6.71B | 6.27B | 5.72B | 5.01B |
Interest Income | 0.00 | 537.30M | 264.76M | 4.74B | 1.96B | 129.30M | 164.44M | 63.65M | 49.99M | 41.99M | 28.16M | 40.50M |
Interest Expense | 1.50B | 744.60M | 856.21M | 5.77B | 2.80B | 631.48M | 387.66M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.59B | 1.59B | 2.79B | 2.72B | 1.12B | 589.91M | 383.35M | 260.77M | 239.20M | 189.81M | 193.00M | 141.18M |
EBITDA | 421.23M | 587.38M | 4.14B | 4.19B | 2.15B | 1.95B | 1.82B | 1.05B | 1.55B | 1.53B | 1.55B | 1.70B |
EBITDA Ratio | 1.58% | 7.05% | 12.71% | 16.94% | 22.91% | 17.14% | 23.03% | 16.12% | 18.11% | 20.92% | 22.82% | 23.79% |
Operating Income | -154.85M | -28.20M | 2.31B | 3.54B | 3.31B | 1.26B | 1.36B | 1.01B | 1.19B | 1.36B | 1.41B | 1.37B |
Operating Income Ratio | -0.58% | -0.08% | 5.76% | 9.58% | 22.91% | 9.38% | 13.79% | 12.82% | 15.08% | 18.36% | 20.07% | 21.56% |
Total Other Income/Expenses | -2.51B | -1.78B | -2.22B | -1.04B | -1.05B | -707.03M | -420.35M | -587.73M | -315.61M | -263.72M | -149.05M | -69.79M |
Income Before Tax | -2.67B | -2.36B | 91.25M | -245.80M | 304.60M | 673.41M | 971.19M | 426.86M | 875.37M | 1.10B | 1.26B | 1.30B |
Income Before Tax Ratio | -9.98% | -6.49% | 0.23% | -0.67% | 2.11% | 5.03% | 9.86% | 5.39% | 11.08% | 14.80% | 17.94% | 20.46% |
Income Tax Expense | -86.40M | 119.60M | -1.05B | 274.70M | 149.10M | 125.03M | 300.94M | 118.62M | 352.64M | 355.17M | 409.94M | 423.98M |
Net Income | -3.32B | -2.48B | 1.05B | -520.50M | 155.50M | 548.38M | 670.25M | 296.70M | 513.51M | 732.82M | 842.61M | 874.38M |
Net Income Ratio | -12.43% | -6.82% | 2.61% | -1.41% | 1.08% | 4.09% | 6.80% | 3.75% | 6.50% | 9.89% | 12.02% | 13.78% |
EPS | 88.56 | -74.21 | 31.16 | -17.22 | 7.38 | 26.24 | 31.57 | 13.94 | 24.60 | 34.85 | 40.18 | 41.41 |
EPS Diluted | 88.15 | -74.21 | 30.75 | -17.22 | 7.38 | 25.83 | 31.57 | 13.94 | 24.60 | 34.85 | 40.18 | 41.41 |
Weighted Avg Shares Out | 1.38B | 1.37B | 1.38B | 1.25B | 865.73M | 861.26M | 865.73M | 860.65M | 860.64M | 859.21M | 860.42M | 862.05M |
Weighted Avg Shares Out (Dil) | 1.38B | 1.37B | 1.40B | 1.25B | 873.85M | 865.73M | 865.73M | 863.20M | 861.06M | 859.25M | 860.44M | 862.07M |
Natura & Co Holding S.A. (NTCOY) Q4 2023 Earnings Call Transcript
Another quarter of improved margins driving turnaround on profitability at Natura &Co
Avon's stock could return to equity markets if this comes to pass
Natura confirms exclusive talks to sell The Body Shop to Aurelius Group
Lloyds Pharmacy owner joins The Body Shop bidding war
Natura &Co: Transformation's Cloudy Horizon
Natura & Co may soon offload The Body Shop
Natura &Co: Available At A Beautiful Value
Natura &Co Holding S.A. (NTCO) Q2 2023 Earnings Call Transcript
Natura &Co Holding S.A. ADR (NTCO) Surges 8.5%: Is This an Indication of Further Gains?
Source: https://incomestatements.info
Category: Stock Reports